Celanese Announces Grant Award to Develop Long-Acting, Refillable Drug Delivery Solution
DALLAS--(BUSINESS WIRE)---- $CE--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced receipt of a grant from the Bill Melinda Gates Foundation to produce and characterize a working prototype for a refillable contraceptive implant. The research and development will be conducted within the Celanese Pharmaceutical Development and Feasibility Lab and the project is expected to produce a functional prototype that meets all established project parameters
Celanese Announces Grant Award to Develop Long-Acting, Refillable Drug Delivery Solution
DALLAS--(BUSINESS WIRE)---- $CE--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced receipt of a grant from the Bill Melinda Gates Foundation to produce and characterize a working prototype for a refillable contraceptive implant. The research and development will be conducted within the Celanese Pharmaceutical Development and Feasibility Lab and the project is expected to produce a functional prototype that meets all established project parameters